1.98 USD
↘ 0.08 (3.88%)AT CLOSE (03:59 PM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
2.00
↗ 0.02 (1.01%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
2.00
↗ 0.02 (1.01%)
Market: CLOSED
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $1.98. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest ABOS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 23, 2026.
Open?$2.05
High?$2.05
Low?$1.90
Prev. Close?$2.06
Volume?537.7K
Avg. Volume?574.0K
VWAP?$1.98
Rel. Volume?0.94x
Bid / Ask
Bid?$1.97 × 2.6K
Ask?$2.03 × 100
Spread?$0.06
Midpoint?$2.00
Valuation & Ratios
Market Cap?143.2M
Shares Out?N/A
Float?40.6M
Float %?56.2%
P/E Ratio?N/A
P/B Ratio?2.50
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
143.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?35
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.86Distress
Confidence?44%Low
Short InterestElevated
Short % of Float?7.58%Elevated
Short Interest?3.1M
Days to Cover?4.8
Free Float40.6M
Avg Daily Volume641.5K
Settlement Date2026-09-30
Financial Health
Current Ratio?2.47Strong
Quick Ratio?2.47Strong
Cash Ratio?1.27Strong
Debt/Equity?0.55Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.50CHEAP▾
Peers100
S&P64
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-183.4%WEAK▾
S&P3
ROA?-90.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-91788000
Enterprise Value?$115.3M
Fundamentals ratios updated end of day